Carpal tunnel syndrome after ciprofloxacin-induced tendinitis

Journal of Clinical Neuromuscular Disease

Volumn 11, Issue 3, 2010, Pages 165-166

  Liang, Vivian Y ^a   Ghearing, Gena R ^b   Živković, Saša A ^b,c  

^a ALLEGHENY GENERAL HOSPITAL   (United States)

^b UNIVERSITY OF PITTSBURGH MEDICAL CENTER   (United States)

^c VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; CIPROFLOXACIN; QUINOLONE DERIVATIVE; STEROID;

AGED; CARPAL TUNNEL SYNDROME; CASE REPORT; EXERCISE; FEMALE; HUMAN; LETTER; MORBIDITY; NEUROPATHY; PRIORITY JOURNAL; TENDINITIS;

AGED; ANTI-INFECTIVE AGENTS; CARPAL TUNNEL SYNDROME; CIPROFLOXACIN; FEMALE; HUMANS; TENDINOPATHY; URINARY TRACT INFECTIONS;

EID: 77949428492     PISSN: 15220443     EISSN: 15371611     Source Type: Journal    
DOI: 10.1097/CND.0b013e3181d23a9c     Document Type: Letter

References (6)

1. Umapathi T, Chaudhry V. Toxic neuropathy. Curr Opin Neurol. 2005;18:574-580.
2. Van Der Linden PD, Sturkenboom MC, Herings RM, et al. Fluoroquinolones and risk of Achilles tendon disorders: case-control study. BMJ. 2002;324:1306-1307.
3. Khaliq Y, Zhanel GG. Fluoroquinolone-associated tendinopathy: a critical review of the literature. Clin Infect Dis. 2003;36:1404-1410.
4. Mehlhorn AJ, Brown DA. Safety concerns with fluoroquinolones. Ann Pharmacother. 2007;41:1859-1866.
5. Wu HT, Schweitzer ME, Culp RW. Potential MR signs of recurrent carpal tunnel syndrome: initial experience. J Comput Assist Tomogr. 2004;28:860-864.
6. Shields R. Levofloxacin-induced small fiber neuropathy. Muscle Nerve. 2009;40:687.